Login / Signup

In vivo stable 211 At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure.

Hiroyuki SuzukiKento KannakaMizuki HirayamaTomoki YamashitaYuta KaizukaRyota KobayashiTakahiro YasudaKazuhiro TakahashiTomoya Uehara
Published in: EJNMMI radiopharmacy and chemistry (2024)
At]At-NpG-D-PSMA should be considered as a potential new TAT for mCRPC.
Keyphrases
  • pet imaging
  • prostate cancer
  • positron emission tomography
  • pet ct
  • benign prostatic hyperplasia
  • cancer therapy
  • drug delivery
  • climate change